Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00739
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 18, 2018
Authors
Publisher
Frontiers Media SA